Qianwei Xing

718 total citations
32 papers, 483 citations indexed

About

Qianwei Xing is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Qianwei Xing has authored 32 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Qianwei Xing's work include Ferroptosis and cancer prognosis (14 papers), Renal cell carcinoma treatment (10 papers) and Cancer-related molecular mechanisms research (7 papers). Qianwei Xing is often cited by papers focused on Ferroptosis and cancer prognosis (14 papers), Renal cell carcinoma treatment (10 papers) and Cancer-related molecular mechanisms research (7 papers). Qianwei Xing collaborates with scholars based in China, Canada and Japan. Qianwei Xing's co-authors include Yi Wang, Shouyong Liu, Zhiqiang Qin, Ran Li, Rong Cong, Yeqing Huang, Zengjun Wang, Limin Ma, Ninghong Song and Min Tang and has published in prestigious journals such as Frontiers in Immunology, European Journal of Immunology and BioMed Research International.

In The Last Decade

Qianwei Xing

30 papers receiving 478 citations

Peers

Qianwei Xing

PRM

ONCOL

SURGE

Yu Ding China

Weili Liu China

Bowen Li China

Weixiang He China

Junjun Ling China

Hongdong Ma China

Jiaheng Fang China

Huzi Xu China

Shichao Guo China

Yu Ding China

Qianwei Xing

236 ×0.8

193 ×1.1

PRM

153 ×1.0

30 ×0.5

ONCOL

40 ×0.8

SURGE

Citations per year, relative to Qianwei Xing Qianwei Xing (= 1×) peers Yu Ding

Countries citing papers authored by Qianwei Xing

Since Specialization

Citations

This map shows the geographic impact of Qianwei Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianwei Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianwei Xing more than expected).

Fields of papers citing papers by Qianwei Xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianwei Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianwei Xing. The network helps show where Qianwei Xing may publish in the future.

Co-authorship network of co-authors of Qianwei Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Qianwei Xing. A scholar is included among the top collaborators of Qianwei Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianwei Xing. Qianwei Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yi, et al.. (2025). The Negative Feedback of the Glutamine/Prostatitis Loop Identified Among 1400 Metabolites and Prostatitis via Mendelian Randomization. Mediators of Inflammation. 2025(1). 9648279–9648279.

Wang, Yi, et al.. (2024). Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients’ populations. Biology Direct. 19(1). 129–129.

Zhang, Xinyu, et al.. (2023). Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing. Biochemical Genetics. 62(3). 1502–1520. 3 indexed citations

Wang, Yi, et al.. (2023). Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC. Genes and Immunity. 24(4). 171–182. 9 indexed citations

Ji, Hao, et al.. (2023). Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity. Heliyon. 9(2). e13201–e13201. 2 indexed citations

Wang, Yi, et al.. (2022). A novel 17 apoptosis-related genes signature could predict overall survival for bladder cancer and its associations with immune infiltration. Heliyon. 8(11). e11343–e11343. 8 indexed citations

Wang, Yi, et al.. (2022). Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma. European Journal of Immunology. 53(1). e2250105–e2250105. 4 indexed citations

Wang, Yi, et al.. (2022). Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms. World Journal of Oncology. 13(1). 27–37. 11 indexed citations

Zhang, Xinyu, et al.. (2022). Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation. Frontiers in Genetics. 13. 974726–974726. 5 indexed citations

10.

Wang, Yi, Ye Tian, Shouyong Liu, Zengjun Wang, & Qianwei Xing. (2021). Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks. Cancer Cell International. 21(1). 625–625. 16 indexed citations

11.

Wang, Yi, et al.. (2021). Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma. Cancer Cell International. 21(1). 46–46. 23 indexed citations

12.

Xing, Qianwei, et al.. (2021). A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence. Pathology - Research and Practice. 225. 153587–153587. 9 indexed citations

13.

Liu, Shouyong, Yi Wang, Chenkui Miao, Qianwei Xing, & Zengjun Wang. (2021). High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity. Cancer Cell International. 21(1). 140–140. 18 indexed citations

14.

Xing, Qianwei, Tengyue Zeng, Shouyong Liu, et al.. (2021). A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. BMC Cancer. 21(1). 381–381. 29 indexed citations

15.

Xing, Qianwei, et al.. (2020). Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma. Cancer Medicine. 9(19). 7034–7051. 9 indexed citations

16.

Xing, Qianwei, et al.. (2019). MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5. BioMed Research International. 2019. 1–8. 28 indexed citations

17.

Zhang, Lei, Yi Wang, Zhiqiang Qin, et al.. (2019). Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis. Journal of Cancer. 11(1). 177–189. 43 indexed citations

18.

Ji, Chengjian, Rong Cong, Yi Wang, et al.. (2019). Relationship between NAMPT/PBEF/visfatin and prognosis of patients with malignant tumors: a systematic review and meta-analysis. Annals of Translational Medicine. 7(23). 785–785. 21 indexed citations

19.

Qin, Zhiqiang, Jingyuan Tang, Qianwei Xing, et al.. (2017). Omega-3 polyunsaturated fatty acids ameliorates testicular ischemia-reperfusion injury through the induction of Nrf2 and inhibition of NF-κB in rats. Experimental and Molecular Pathology. 103(1). 44–50. 22 indexed citations

20.

Wu, You, et al.. (2013). MTHFR C677T and A1298C Polymorphisms Were Associated with Bladder Cancer Risk and Disease Progression: A Meta-Analysis. DNA and Cell Biology. 32(5). 260–267. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact